Beijing LabTech Instruments Co Gross Profit
The Gross Profit of Beijing LabTech Instruments Co (688056.SS) as of Jul 14, 2026 is 190.94 M CNY. In the previous year, Gross Profit was 182.00 M CNY — a change of 4.91% (higher).
Get this data via API
Financial Data API
Gross Profit
190.94 MCNY
YoY
4.91%
Last updated:
Gross Profit of Beijing LabTech Instruments Co is 2026 190.94 M CNY. Gross Profit of Beijing LabTech Instruments Co was 2025 182.00 M CNY. It decreases by 4.91% higher compared to the previous year.
The Beijing LabTech Instruments Co Gross Profit history
3 Years
10 Years
25 Years
Max
GROSS MARGIN (%)
Date
GROSS MARGIN (%)
Jan 1, 2020
48.68 base
Jan 1, 2021
48.36 base
Jan 1, 2022
47.51 base
Jan 1, 2023
43.75 base
Jan 1, 2024
45.03 base
Jan 1, 2025 (e)
42.20 base
Jan 1, 2026 (e)
40.31 base
Jan 1, 2027 (e)
38.42 base
| YEAR | GROSS MARGIN (%) |
|---|---|
| 2027 est | 38.42 |
| 2026 est | 40.31 |
| 2025 est | 42.20 |
| 2024 | 45.03 |
| 2023 | 43.75 |
| 2022 | 47.51 |
| 2021 | 48.36 |
| 2020 | 48.68 |
| 2019 | 46.28 |
| 2018 | 48.24 |
| 2017 | 51.82 |
Access this data via the Eulerpool API
Beijing LabTech Instruments Co Revenue
Beijing LabTech Instruments Co Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
348.60 M CNY
68.30 M CNY
65.20 M CNY
Jan 1, 2021
368.90 M CNY
68.10 M CNY
69.40 M CNY
Jan 1, 2022
355.00 M CNY
43.30 M CNY
44.62 M CNY
Jan 1, 2023
416.00 M CNY
26.30 M CNY
27.56 M CNY
Jan 1, 2024
424.01 M CNY
43.77 M CNY
39.15 M CNY
Jan 1, 2025 (e)
452.48 M CNY
58.58 M CNY
50.41 M CNY
Jan 1, 2026 (e)
473.69 M CNY
83.83 M CNY
58.59 M CNY
Jan 1, 2027 (e)
496.92 M CNY
99.99 M CNY
67.44 M CNY
Beijing LabTech Instruments Co Margins
Beijing LabTech Instruments Co stock margins
The Beijing LabTech Instruments Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Beijing LabTech Instruments Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Beijing LabTech Instruments Co.
3 Years
5 Years
10 Years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
48.68 %
19.59 %
18.70 %
Jan 1, 2021
48.36 %
18.46 %
18.81 %
Jan 1, 2022
47.51 %
12.20 %
12.57 %
Jan 1, 2023
43.75 %
6.32 %
6.63 %
Jan 1, 2024
45.03 %
10.32 %
9.23 %
Jan 1, 2025 (e)
45.03 %
12.95 %
11.14 %
Jan 1, 2026 (e)
45.03 %
17.70 %
12.37 %
Jan 1, 2027 (e)
45.03 %
20.12 %
13.57 %
Beijing LabTech Instruments Co Stock analysis
What does Beijing LabTech Instruments Co do? Beijing LabTech Instruments Co is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Beijing LabTech Instruments Co stock
Gross Profit of Beijing LabTech Instruments Co is 190.94 M CNY in 2026.
Access this data via the Eulerpool API
Income Statement — Beijing LabTech Instruments Co
All Key Metrics — Beijing LabTech Instruments Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth